Patent Assignment
Reel/Frame 061337/0797
Assignment of Assignor's Interest
Recorded: 2022-10-06
Pages: 3
Assignee
CYDEX PHARMACEUTICALS, INC.
10513 W. 84TH TERRACE, LENEXA, KANSAS, 66214
Covered Properties
(3)
DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 6, 2022
From: PIPKIN, JAMES D.
To: CYDEX, INC.
Reel/Frame 061337/0713 →
Change of Name
Oct 6, 2022
From: CYDEX, INC.
To: CYDEX PHARMACEUTICALS, INC.
Reel/Frame 061621/0152 →
Security Interest
Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →